Physicians Take Oath in Ruins Where Hippocrates Trained
December 1st 1995On the Greek island of Kos in the southeast Aegean, there is a cypress covered hill where ancient springs flow and herbs grow in abundance. People searching for good health have been coming to this hill for 25 generations. Hippocrates was born on Kos, and the hill holds the ruins of the ancient healing place, the Asclepieion.
1 Million Americans a Day Risk Injury in Tanning Salons
December 1st 1995BUENOS AIRES--The tanning salon industry has grown enormously in recent years, with as many as 2 million regular patrons in the United States, and 1 million people visiting daily, W. L. Morrison, MD, of Johns Hopkins University, said at the Sixth World Congress on Cancers of the Skin.
Pretreatment Levels of Hemoglobin May Predict Outcomes of Larynx Cancer Patients
December 1st 1995MIAMI BEACH--Pretreatment hemoglobin level has been shown to have an independent effect on local control and survival in patients with T1-T2 squamous cell carcinomas of the glottic larynx, Douglas A. Fein, MD, reported at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). Based on this finding, it may be advisable to correct anemia in these patients before starting radiation therapy, he said.
Total Outpatient Program Cuts Transplant Cost
November 1st 1995LUXEMBOURG-In an effort to beat the skyrocketing costs of high-dose chemotherapy and transplantation, physicians at the Scripps Clinic, La Jolla, Calif, have launched a total outpatient therapy program that attempts to eliminate expensive hospital admissions.
DNA Repair Enzyme Decreases Skin Cancer Incidence in Animals
November 1st 1995BUENOS AIRES-Ultraviolet (UV) radiation contributes to skin cancer induction not only by transforming normal cells to cancer cells but also by impairing the host immune response to skin cancer, said Daniel Yarosh, PhD, president of Applied Genetics, Inc., Freeport, NY.
Notion of 'Global' Microbial Resistance May Be Oversimplified
November 1st 1995MONTREAL-The rising worldwide incidence of microbial resistance stems from a wide variety of causes and does not reflect a single global trend or etiology, Prof. Dr. Bernd Wiedemann, University of Bonn, Germany, said at a plenary session of the 19th International Congress of Chemotherapy.
Outpatient Oral Antibiotics Safe, Effective
November 1st 1995LUXEMBOURG-Outpatient oral antibiotic therapy can be as effective and safe as outpatient parenteral therapy in the treatment of febrile neutropenia, according to the latest trial results from M.D. Anderson Cancer Center's Ambulatory and Supportive Care Oncology Research Program (ASCORP).
Despite New Therapies, Malignant Pleural Mesothelioma Outcomes Are Not Improved
November 1st 1995BUFFALO, NY-While a combination of pleurectomy and intracavitary photodynamic therapy marginally improves survival rates for some patients with malignant pleural mesothelioma, "there exists no compelling evidence that treatment of any kind is superior to no treatment," reported Hiroshi Takita, MD, DSc, chief of the Department of Thoracic Surgery, Roswell Park Cancer Institute.
Use of Clarithromycin Prophylaxis Reduces MAC Infection, Mortality in Advanced AIDS Patients
November 1st 1995SAN FRANCISCO-Clarithromy-cin (Biaxin), a newer generation macro-lide, has been shown to have a definite favorable effect on survival when given prophylactically to patients with advanced AIDS, Mark Pierce, MD, reported at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy.
Low-Dose Acyclovir Recommended for HSV Prophylaxis in Leukemic Patients
November 1st 1995SAN FRANCISCO-Low-dose intravenous acyclovir (Zovirax) provides effective prophylaxis against Herpes simplex virus (HSV) infection or reactivation in leukemic patients undergoing intensive chemotherapy, Carole Miller, MD, said at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
Study Shows Outpatient Chemotherapy Less Expensive Than Home Health Care Delivery
November 1st 1995MARINA DEL REY, Calif-A detailed financial analysis of the costs associated with chemotherapy delivery showed home health care costs to be, on average, 2.5 times higher than those incurred in an outpatient clinic setting, said Patrick A. Grusenmeyer, MPA, financial administrator for the Ochsner Cancer Institute, New Orleans.
Extended Triple Antiretroviral Therapy Maintains Superiority
November 1st 1995SAN FRANCISCO-Two separate clinical trials have demonstrated that triple combination antiretroviral therapy maintains its superiority over double therapy in the extended treatment of HIV infection, although neither study included clinical morbidity as an endpoint.
Amphotericin B Lipid Complex Effective, Less Toxic
November 1st 1995SAN FRANCISCO-Amphotericin B lipid complex may be the treatment of choice for patients with hematogenous or invasive candidiasis, Elias J. Anaissie, MD, said at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
Careful Appraisal Is Needed to Determine The True Value of an Oncology Practice
November 1st 1995MARINA DEL REY, Calif-Every physician needs to know the value of his or her practice, especially in this era of change-when mergers, affiliations, partner buy-ins or buy-outs, and outright sales of practices are common, Kim R. Johnson, RN, said at the annual conference of the Association of Community Cancer Centers (ACCC).
Market Research Provides Critical Information to Cancer Centers
November 1st 1995MARINA DEL REY, Calif-In today's health care environment, the providers of cancer care must determine not only how to market their services but also whom to market them to, Patti A. Jamieson, MSSW, MBA, said at the annual Conference of the Association of Community Cancer Centers (ACCC).